Skip to main
ADNT

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 25%
Buy 13%
Hold 50%
Sell 13%
Strong Sell 0%

Bulls say

Adient is recognized as a leading seating supplier with a consolidated revenue of $14.5 billion in fiscal 2025, excluding joint venture sales, which reflects its substantial presence in the global automotive market. The company anticipates growth from onshored production, with management projecting that targeted share gains from reshored programs could potentially double its current market share. Furthermore, management expects to achieve margin expansion to a range of 5.0%-5.5% in the next 2-3 years, indicating a positive trajectory for profitability.

Bears say

Adient faces ongoing challenges stemming from loss-making metals contracts and uncompetitive plants inherited from its spin-off, which have significantly hindered profitability and cash flow. The company's revenue in the EMEA region is adversely affected by decreasing vehicle production and an unfavorable production mix, compounding its financial difficulties. Additionally, persistent geopolitical and macroeconomic factors are expected to further impede European production, contributing to an overall negative financial outlook for Adient.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.81, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.81, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.